In this study, after individuals were given cysteine and glycine, the results found that not only did glutathione improve, but the cellular damage that generally occurs with high sugar levels was reduced (8)
and 0.82 (0.70-0.95
Last month (May 2025), Novo announced that the US Food and Drug Administration (FDA) accepted its new drug application (NDA) submission for an investigational once-daily oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease
Perleth M, Langer G, Meerpohl JJ, Gartlehner G, Kaminski-Hartenthaler A, Schnemann HJ
Cost-benefit analysis depends on individual goals, timeframe, and medical needs
depending on your condition, the herb could make it worse